| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,729 |
2,538 |
$337K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,133 |
886 |
$204K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
816 |
768 |
$117K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
389 |
354 |
$102K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
83 |
80 |
$6K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
16 |
14 |
$5K |
| J3490 |
Unclassified drugs |
5,607 |
1,654 |
$4K |
| 73221 |
|
16 |
14 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
96 |
88 |
$2K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
24 |
12 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
845 |
713 |
$1K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
682 |
623 |
$1K |
| 80053 |
Comprehensive metabolic panel |
546 |
507 |
$945.72 |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
13 |
12 |
$698.02 |
| 97161 |
|
91 |
81 |
$552.56 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
14 |
14 |
$461.93 |
| 81025 |
|
345 |
320 |
$451.09 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
39 |
36 |
$233.01 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,026 |
641 |
$202.33 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
12 |
12 |
$198.60 |
| 76942 |
|
257 |
220 |
$166.32 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,058 |
880 |
$123.23 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
755 |
686 |
$93.79 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
717 |
560 |
$75.11 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
460 |
396 |
$32.16 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
69 |
52 |
$0.00 |
| 81001 |
|
17 |
16 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
634 |
510 |
$0.00 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
112 |
103 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
146 |
126 |
$0.00 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
12 |
12 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
16 |
13 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
87 |
72 |
$0.00 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
285 |
192 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
387 |
354 |
$0.00 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
47 |
38 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
19 |
17 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
16 |
13 |
$0.00 |